6 Samtidig administration af rosiglitazon og rifampicin (en inducer af CYP2C8) resulterede i et fald på 66% i rosiglitazon plasmakoncentrationer.
6 Co-administration of rosiglitazone with rifampicin (an inducer of CYP2C8) resulted in a 66% decrease in rosiglitazone plasma concentrations.